Patient Care

This page includes news coverage of various aspects of patient healthcare, including new technology innovations, what is working, what is not, personalized medicine and remote and telemedicine delivery. Find specific news in the areas of Care DeliveryDigital TransformationPrecision MedicineRemote Monitoring and Telehealth.

Thumbnail

Can COVID-19 cause, uncover or otherwise activate diabetes?

As many as 14% of patients with severe COVID-19 develop type I or type II diabetes––and doctors are bewildered by the association. 

 

Thumbnail

Routine chest imaging all AI needs to spot impending heart maladies

AI has proven capable of automatically detecting looming heart trouble on CT scans taken for lung issues like lung cancer, pulmonary embolism and pneumonia.

Telehealth, AI will drive healthcare delivery revolution through 2030

Technology adoption in healthcare is at an all-time high, and the attractiveness of telehealth and other innovative solutions during the COVID-19 pandemic is likely to continue driving how healthcare is delivered through the next decade.

 

Americans much more wary than South Koreans about sharing whereabouts to help counter COVID

The researchers solicited 306 adults—188 in the U.S. and 118 in South Korea—for their views on contact tracing, quarantine monitoring and public mapping of sites recently visited by COVID-positive individuals.

AI recognizes cognitive decline in headshots

Researchers have used deep learning software to accurately detect age-related cognitive impairment using only photos of patients’ faces.

Telemedicine gaining fans in dermatology

Fewer than 10% of dermatology patients who were seen virtually during the COVID pandemic said they would not use teledermatology again—and only 7% said they’d not recommend telehealth to a friend.

Thumbnail

Going by online browsing patterns, telehealth will remain a force after COVID

Google searches for “telehealth” have fallen far since peaking in March 2020. However, the term is plateauing at a rate that’s 320% higher than in pre-pandemic times.

AI learns COVID’s language to predict its next move

The idea is to head off serious gathering threats without getting thrown off the scent by strains unlikely to proliferate.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.